๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Autoimmune Diseases
Clinical trial register · China

Autoimmune Diseases Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 10 Hangzhou 9 Wuhan 6 Shanghai 5 Hefei 4
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing10 Hangzhou9 Wuhan6 Shanghai5 Hefei4
All 17 locations
Target enrolment
to

Autoimmune Diseases trials in China

37 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
NCT06435897Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
CAR-T Cells Targeting Autoimmune Diseases
NCT05459870Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-01
Not yet open
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases
Antengene Biologics Limited
Phase 1
149
Bengbu, Hefei, Beijing, Xiamen, Guangzhou, Luoyang, Zhengzhou, Wuhan
2026-09-01
Not yet open
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
NCT07674147Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory Myopathies
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
30
Nanjing, Hangzhou
2026-07
Not yet open
Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases
NCT07613411Autoimmune Diseases
Chinese PLA General Hospital
Phase EARLY_PHASE1
60
Beijing
2026-06-01
Recruiting
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
NCT07586267Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
15
Hangzhou
2026-05-08
Recruiting
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
NCT07507201Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
15
Hangzhou
2026-04-01
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT07246096Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Sclerosis, Primary Sjรถgren Syndrome
Changhai Hospital
Phase EARLY_PHASE1
60
Shanghai
2026-02-20
Recruiting
Clinical Study of AFN50 Injection in the Autoimmune Diseases
NCT07408336Autoimmune Diseases
DrugAFN50
AlphaNa Bioscience Company Limited
Phase EARLY_PHASE1
18
Hefei
2026-02-04
Recruiting
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
NCT07283315Paediatric B Cell-related Autoimmune Diseases, Autoimmune Diseases, CAR
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
12
Hangzhou
2025-12-03
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
NCT07305116Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
15
Hangzhou
2025-12-01
Not yet open
A Study of CAR-T Cells in Subjects With Autoimmune Diseases
NCT07040917Autoimmune Diseases
Chinese PLA General Hospital
Phase EARLY_PHASE1
12
Beijing
2025-09-30
Not yet open
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
NCT07161193Autoimmune Diseases
Hebei Senlang Biotechnology Inc., Ltd.
Phase 1/2
30
Luoyang
2025-09-30
Recruiting
Exploratory Clinical Study on the Safety of STR-P004
NCT07143617Autoimmune Diseases
Beijing GoBroad Hospital
Not applicable
39
Beijing
2025-09-16
Recruiting
Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
NCT07121777Autoimmune Diseases
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-08-25
Recruiting
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
NCT07122076Autoimmune Diseases
DrugGT719
Grit Biotechnology
Phase EARLY_PHASE1
10
Shanghai
2025-08-22
Recruiting
CAR-T Therapy for Refractory Autoimmune Diseases
NCT07059169Autoimmune Diseases
DrugJY231
LiangZou
Not applicable
20
Wuhan
2025-08-04
Recruiting
CAR-T Cells Therapy for Patients With Autoimmune Diseases
NCT07052565Autoimmune Diseases
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-07-20
Recruiting
Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
NCT06792799Autoimmune Diseases, Systemic Lupus Erthematosus, Multi-Drug Resistant Nephrotic Syndrome, IgAN - IgA Nephropathy
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
36
Hangzhou
2025-01-30
Not yet open
A Study of CAR-T Cells in Subjects with Autoimmune Diseases
NCT06762119Autoimmune Diseases
Zhejiang University
Phase EARLY_PHASE1
6
Hangzhou
2025-01-10
Recruiting
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
NCT06747156Autoimmune Diseases
Ruijin Hospital
Phase EARLY_PHASE1
66
Wuhan, Nanjing, Shanghai
2024-12-23
Recruiting
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
NCT06688799Autoimmune Diseases
Beijing GoBroad Hospital
Phase 1/2
18
Beijing
2024-11-23
Recruiting
CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT06680388Autoimmune Diseases
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
15
Tianjin
2024-11-15
Not yet open
A Study of CAR-T Cells Targeting Autoimmune Diseases
NCT06661811Autoimmune Diseases
Beijing Boren Hospital
Not applicable
12
Beijing
2024-11-15
Not yet open
JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
NCT06567080B-cell Tumors, Autoimmune Diseases, Lupus Erythematosus, Systemic, Large B-cell Lymphoma
RenJi Hospital
Phase 1
15
Shanghai
2024-09
Recruiting
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
NCT06499233Pneumonia, Pneumocystis, Autoimmune Inflammatory Rheumatic Disease, Autoimmune Diseases, Connective Tissue Disease
Tongji Hospital
Phase 4
800
Wuhan
2024-07-20
Recruiting
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
NCT06350110Systemic Lupus Erythematosus, Lupus Nephritis, Autoimmune Diseases, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Essen Biotech
Phase 1/2
75
Beijing
2024-07-10
Recruiting
An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT06464679Autoimmune Diseases
Changhai Hospital
Phase 1
72
Shanghai
2024-06-27
Recruiting
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
NCT06428188Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Acute, Sjogren's Syndrome
Essen Biotech
Phase 1/2
60
Beijing
2024-05-29
Recruiting
CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases
NCT06279923Autoimmune Diseases
Zhejiang University
Phase EARLY_PHASE1
45
Hangzhou
2024-04-15
Recruiting
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
NCT06503224Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China
Not applicable
18
Changsha
2024-04-09
Recruiting
A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases
NCT06318533Autoimmune Diseases
YANRU WANG
Phase EARLY_PHASE1
15
Zhenjiang
2024-03-13
Not yet open
JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases
NCT06243159Autoimmune Diseases
Shanxi Bethune Hospital
Phase EARLY_PHASE1
20
Taiyuan
2024-02-08
Recruiting
Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement
NCT05789030Autoimmune Diseases
Peking Union Medical College Hospital
Not applicable
60
Beijing
2022-07-01
Recruiting
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
NCT06417502Autoimmune Diseases, Autoinflammatory Diseases
Peking Union Medical College Hospital
Observational
20,000
Beijing, Chongqing, Shenzhen, Changsha, Nanjing, Hangzhou
2022-04-29
Recruiting
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
NCT04561557Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Myasthenia Gravis
Tongji Hospital
Phase EARLY_PHASE1
36
Wuhan
2020-09-22
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/autoimmune-diseases

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies listing the condition Autoimmune Diseases.

How many Autoimmune Diseases trials are recruiting in China?

26 of the 37 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 11 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Autoimmune Diseases), 37 studies
PhaseStudiesRecruitingShare
Phase EARLY_PHASE1171245.9%
Not applicable8721.6%
Phase 1/26316.2%
Phase 14210.8%
Observational112.7%
Phase 4112.7%

Most active sponsors

Lead sponsors with the most studies (Autoimmune Diseases)
Lead sponsorStudiesRecruiting
The Children's Hospital of Zhejiang University School of Medicine65
Anhui Provincial Hospital22
Beijing GoBroad Hospital22
Changhai Hospital22
Chinese PLA General Hospital20
Essen Biotech22
Peking Union Medical College Hospital22
Shenzhen Geno-Immune Medical Institute20
Tongji Hospital22
Zhejiang University21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.